Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse for executive function post-oophorectomy
NCT03187353Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Sep 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine in cognitive impairment, sponsored by University of Pennsylvania. Started Sep 2017; status: completed.
02
Drugs
lisdexamfetamine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT03187353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03187353.